LSNE Appoints New COO - - BioPharm International

ADVERTISEMENT

LSNE Appoints New COO



Untitled Document

Lyophilization Services of New England (LSNE), a New Hampshire based contract-manufacturing organization, has appointed Shawn Cain as COO, a new position within the company. Cain joined LSNE in 2012 as vice- president of sterile manufacturing. In his new role, Cain will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals. Cain will report to Matthew Halvorsen, president and CEO of LSNE. Cain's 28-year career includes experience in the pharmaceutical, biotech, and medical device industries. Cain has held management positions within operations at Organogenesis, Formatech, Arbios Systems, and Becton Dickinson.

Source: LSNE

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here